Cargando…
Biotransformation of beta-endorphin and possible therapeutic implications
Autores principales: | Asvadi, Naghmeh H., Morgan, Michael, Hewavitharana, Amitha K., Shaw, P. Nicholas, Cabot, Peter J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3928545/ https://www.ncbi.nlm.nih.gov/pubmed/24600392 http://dx.doi.org/10.3389/fphar.2014.00018 |
Ejemplares similares
-
Beta-Endorphin 1–31 Biotransformation and cAMP Modulation in Inflammation
por: Asvadi, Naghmeh Hajarol, et al.
Publicado: (2014) -
Bio-Guided Fractionation of Papaya Leaf Juice for Delineating the Components Responsible for the Selective Anti-proliferative Effects on Prostate Cancer Cells
por: Pandey, Saurabh, et al.
Publicado: (2018) -
BETA ENDORPHINS - HOLISTIC THERAPEUTIC APPROACH TO CANCER
por: Shrihari, T.G.
Publicado: (2019) -
The effects of Beta-Endorphin: state change modification
por: Veening, Jan G, et al.
Publicado: (2015) -
Dynorphin 1-17 and Its N-Terminal Biotransformation Fragments Modulate Lipopolysaccharide-Stimulated Nuclear Factor-kappa B Nuclear Translocation, Interleukin-1beta and Tumor Necrosis Factor-alpha in Differentiated THP-1 Cells
por: Fazalul Rahiman, Siti Sarah, et al.
Publicado: (2016)